Tabraiz A Mohammed

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. pmc A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma
    Tabraiz A Mohammed
    D O, M S, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Madison, Wisconsin 53792, USA
    Oncologist 16:835-43. 2011
  2. pmc A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer
    William R Schelman
    University of Wisconsin Carbone Cancer Center, 600 Highland Avenue, K4 530 CSC, Madison, WI, 53792, USA
    Invest New Drugs 32:295-302. 2014

Collaborators

Detail Information

Publications2

  1. pmc A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma
    Tabraiz A Mohammed
    D O, M S, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Madison, Wisconsin 53792, USA
    Oncologist 16:835-43. 2011
    ..Thus, this study aimed to evaluate the role of VPA in treating NETs and to determine whether VPA induced the Notch signaling pathway signaling in vivo...
  2. pmc A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer
    William R Schelman
    University of Wisconsin Carbone Cancer Center, 600 Highland Avenue, K4 530 CSC, Madison, WI, 53792, USA
    Invest New Drugs 32:295-302. 2014
    ....